BAM66495
TG101209
TG101209 is a potent and small molecule JAK2-selective kinase inhibitor with IC50 of 6, 25, 17 and 169 nM for JAK2, FLT3, RET and JAK3, respectively.
|
Quantity
Price
5 mg
170.00
10 mg
320.00
50 mg
970.00
200 mg
2470.00
|
|
C26H35N7O2S
|
|
98+%
|
MFCD15528085
|
|
BAM66409
Ruxolitinib
INCB018424 (Ruxolitinib) is an orally bioavailable JAK inhibitor (IC50 values for JAK1, JAK2 and JAK3 are 3, 5 and 332 nM, respectively).
|
Quantity
Price
5 mg
99.00
10 mg
165.00
50 mg
470.00
100 mg
725.00
200 mg
1180.00
|
|
C17H18N6
|
941678-49-5
|
98+%
|
MFCD12031592
|
|
BAM66411
LY2784544
LY2784544 is a small molecule selective mutant JAK2 kinase inhibitor with an IC50 of 68 nM.
|
Quantity
Price
5 mg
80.00
10 mg
160.00
50 mg
550.00
200 mg
1570.00
|
|
C23H25ClFN7O
|
1229236-86-5
|
98+%
|
MFCD19443122
|
|
BAM66409
INCB018424
INCB018424 (Ruxolitinib) is an orally bioavailable JAK inhibitor (IC50 values for JAK1, JAK2 and JAK3 are 3, 5 and 332 nM, respectively).
|
Quantity
Price
5 mg
99.00
10 mg
165.00
50 mg
470.00
100 mg
725.00
200 mg
1180.00
|
|
C17H18N6
|
941678-49-5
|
98+%
|
MFCD12031592
|
|
BAM66416
CYT387
CYT387 is an ATP-competitive small molecule JAK1/JAK2 inhibitor with IC50 of 11 and 18 nM for JAK1 and JAK2, respectively.
|
Quantity
Price
10 mg
99.00
50 mg
450.00
200 mg
950.00
|
|
C23H22N6O2
|
1056634-68-4
|
98+%
|
MFCD16038899
|
|
|